Classification of cardioactive drugs in vivo by using programmed electrical stimulation in combination with monophasic action potential recordings at different pacing rates

Acta Medica Scandinavica. Supplementum
K LandmarkH Refsum

Abstract

The effect of antiarrhythmic drugs on myocardial refractoriness may be due to changes either in Vmax of phase 0 or the phase of repolarization of the AP or both. By using programmed electrical stimulation in combination with MAP recordings at different pacing rates in the intact dog heart, it was possible to classify and to a certain extent to elucidate the mode of action of various cardioactive drugs in vivo.

References

Aug 24, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·P ArlockS R Olsson
May 1, 1977·Circulation·A H GradmanD C Harrison
Jan 1, 1978·British Heart Journal·J W MasonD C Harrison
May 1, 1978·Acta Pharmacologica Et Toxicologica·E N Petersen
Feb 11, 1975·Clinical Pharmacology and Therapeutics·J ElsonA J Atkinson
Jan 1, 1975·European Journal of Clinical Pharmacology·P BironG Tremblay
Aug 1, 1968·Circulation·R ShabetaiW Hammill
Aug 1, 1974·British Heart Journal·S B Olsson
Jan 1, 1973·Circulation Research·M R Rosen, B F Hoffman
Jan 1, 1972·Pflügers Archiv : European journal of physiology·M KohlhardtA Fleckenstein
Jun 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·D E DrayerR W Sevy
Jul 1, 1969·Progress in Cardiovascular Diseases·D Gibson, E Sowton
Jan 1, 1969·Pflügers Archiv : European journal of physiology·O RougierE Coraboeuf
Dec 1, 1969·Circulation·W D BerkowitzA N Damato
Aug 1, 1970·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Mar 1, 1970·The Journal of Physiology·G W Beeler, H Reuter
Mar 1, 1971·The Journal of General Physiology·G Giebisch, S Weidmann
Nov 1, 1966·Circulation Research·D G Kassebaum, A R Van Dyke
Oct 1, 1967·Circulation Research·D H SingerB F Hoffman
Oct 1, 1954·The American Journal of Physiology·B F HOFFMAN, E E SUCKLING
Sep 1, 1957·The American Journal of Physiology·B F HOFFMANE E SUCKLING
Jun 1, 1959·The American Journal of Physiology·B F HOFFMANH C HERRLICH
Mar 1, 1962·Circulation Research·W TRAUTWEIN HECHTHH
Jan 1, 1964·Circulation Research·A G WALLACE, S J SARNOFF
Jan 1, 1960·Circulation Research·R L KLEINB TINSLEY

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.